COMP <GO>
TDOC vs ADUS // RSI-14 & 200D SMA MOMENTUM
Teladoc Health Inc. (NYSE) VS. Addus HomeCare Corporation (NASDAQ) • 15-METRIC TALLY: TDOC 2
— ADUS 8
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TDOC
LAST: $8.73 (+26.89%) • MKT CAP: $1.59B
rsi-technicals
79.0
LAST: $124.34 (+1.77%) • MKT CAP: $2.32B
rsi-technicals
73.1
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. ADUS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TDOC | ADUS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 32.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -17.00% | 9.10% | -26.10 | ADUS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.8x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 18.00% | 4.47% | +13.53 | TDOC | /fcf-yield <GO> |
| Operating Margin | -10.40% | 9.70% | -20.10 | ADUS | /operating-margins <GO> |
| Net Profit Margin | -7.90% | 6.70% | -14.60 | ADUS | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 23.20% | -24.70 | ADUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.83 | -5.38 | ADUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | ADUS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 79.0 | 73.1 | +5.89 | TDOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 20.3x | +11.70 | ADUS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $2.32B | -$735.9M | ADUS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TDOC REV | ADUS REV | TDOC GROSS % | ADUS GROSS % | TDOC FCF | ADUS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $1.42B | — | 32.5% | $285.5M | $103.8M |
| FY 2024 | $2.57B | $1.15B | — | 32.5% | $282.9M | $110.4M |
| FY 2023 | $2.60B | $1.06B | — | — | $232.9M | $112.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
ADUS // BETA —